RBR-2kwny8
Active, not recruiting
未知
Evaluation of the inhalation technique in patients with bronchial asthma after intervention
Faculdade de Medicina da Universidade Federal Fluminense0 sitesDecember 27, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Faculdade de Medicina da Universidade Federal Fluminense
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with incorrect inhalation technique selected from previous study.
- •Over 18 years of age
- •Does not present with an exacerbation on the day of the consultation
- •Does not need help from other party to use inhaler
Exclusion Criteria
- •Patients using a spacer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20200511047396N1CinnaGen company50
Active, not recruiting
Not Applicable
Improving health outcomes for Jordanian outpatients with asthmaAsthmaRespiratory - AsthmaACTRN12610000159055Applied Science University114
Recruiting
Not Applicable
Investigation of effectiveness of inhalation intake of beta-caryophyllene (BCP) against vascular wall stiffening caused by smoking.SmokerJPRN-UMIN000049675Sunsho Pharmaceutical Co.,Ltd.90
Completed
Not Applicable
A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)COPD and sPAHJPRN-UMIN000002080Tohoku University20
Completed
Phase 3
Clinical Trial To Assess The Efficacy And Safety Of Oral Inhalation Of Fixed Dose Combination Of Glycopyrronium and Formoterol Fumarate Powder for Inhalation As Compared To Marketed Glycopyrronium Powder for Inhalation in COPD patientsCTRI/2017/09/009804Restech Pharmaceuticals330